Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Saul H Rosenthal who wrote (2093)	5/5/1998 7:28:00 PM
From: Anthony Wong	Respond to of 9523

May 05, 1998 (6:13 PM ET) - The Motley Fool Evening News MacroChem Corp. (Nasdaq:MCHM - news) tumbled $3/4 to $12 after The Wall Street Journal's "Heard on the Street" column reported that the drug company is a favorite among short sellers and has risen on the coattails of Pfizer's (NYSE:PFE - news) fast-selling impotence drug Viagra. MacroChem has risen more than 40% since mid-April, just before the first reports of the immensely successful sales of Viagra. Short interest in the stock soared 66% between mid-March and mid-April. The company claims that clinical tests of its Topiglan gel impotence treatment show a 75% to 80% efficacy rate. Investors shorting the stock are probably focusing on rumors that the gel didn't yield decent results when applied in small dosages and caused burning when larger amounts were used during clinical trials. MachroChem acknowledges that men suffered some discomfort in early tests, but says that has been remedied by applying the gel to a limited area. The drug has yet to break out of the development stage.

To: Saul H Rosenthal who wrote (2093)	5/5/1998 7:29:00 PM
From: Richard L. Rethi	Read Replies (1) \| Respond to of 9523

OK! Sell your PFE. Dan Rather, CBS, just stated that taking Viagra causes retina damage. The news people are the expert on any topic. All the people that listen to the news will now stop taking this drug. Give me a break!

To: Saul H Rosenthal who wrote (2093)	5/5/1998 7:39:00 PM
From: John Chatterton	Respond to of 9523

Actually, 30 percent of Viagra users will be tempted to use Muse, because V. won't work for them. And these are people who would probably otherwise not have tried Muse, because they hand't yet admitted to themselves they suffered from ED and didn't want to use a suppository. Once they broke the ice with V., it would be easier to try Muse. Does anyone know what percentage of Muse users meet with success? What if V. doesn't work for them? (V. and M. use different mechanisms.)

To: Saul H Rosenthal who wrote (2093)	5/5/1998 10:09:00 PM
From: James Baker	Respond to of 9523

saul: Sorry, Craig. Noone who ever uses Viagra will go back to Vivus...side-effects or no side-effects.>>> Edderd a Urologist on the SI Vivus boards says that they are starting to see regular calls from those who wanted to try Viagra but were not helped and want a refill on their MUSE. There is a place for MUSE in the treatment of REAL organic ED! Jim